Dongbang Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	108,481	105,114	90,875	81,408
Revenue Growth (YoY)	15.96%	15.67%	11.63%	-
Cost of Revenue	72,119	71,020	60,134	58,887
Gross Profit	36,362	34,094	30,741	22,520
Selling, General & Admin	15,852	14,821	11,972	11,240
Research & Development	2,707	2,591	2,100	1,798
Other Operating Expenses	346.65	361.01	286.9	572.2
Operating Expenses	20,032	18,618	13,560	16,961
Operating Income	16,330	15,476	17,182	5,560
Interest Expense	-1,624	-1,956	-2,613	-1,308
Interest & Investment Income	219.21	201.48	86.23	40.72
Earnings From Equity Investments	-	-	45.53	-
Currency Exchange Gain (Loss)	694.78	1,080	-202.05	734.38
Other Non Operating Income (Expenses)	-9,181	-9,270	-1,182	1,159
EBT Excluding Unusual Items	6,439	5,532	13,317	6,186
Gain (Loss) on Sale of Investments	-641.77	-727.67	-709.31	-537.95
Gain (Loss) on Sale of Assets	1,986	1,986	-102.65	-28.47
Pretax Income	7,783	6,791	12,505	5,619
Income Tax Expense	3,848	3,663	2,771	2,300
Earnings From Continuing Operations	3,935	3,127	9,734	3,320
Minority Interest in Earnings	-219.8	-212.84	40.46	-127.95
Net Income	3,715	2,914	9,775	3,192
Net Income to Common	3,715	2,914	9,775	3,192
Net Income Growth	-60.20%	-70.19%	206.26%	-
Shares Outstanding (Basic)	17	16	15	15
Shares Outstanding (Diluted)	17	16	17	15
Shares Change (YoY)	-3.17%	-7.51%	17.90%	-
EPS (Basic)	214.90	180.07	658.62	215.05
EPS (Diluted)	214.90	180.07	617.82	215.05
EPS Growth	-63.00%	-70.85%	187.29%	-
Free Cash Flow	1,501	5,408	1,811	4,379
Free Cash Flow Per Share	86.84	334.19	103.53	295.08
Gross Margin	33.52%	32.44%	33.83%	27.66%
Operating Margin	15.05%	14.72%	18.91%	6.83%
Profit Margin	3.43%	2.77%	10.76%	3.92%
Free Cash Flow Margin	1.38%	5.15%	1.99%	5.38%
EBITDA	22,766	21,640	22,630	10,832
EBITDA Margin	20.99%	20.59%	24.90%	13.31%
D&A For EBITDA	6,436	6,164	5,448	5,272
EBIT	16,330	15,476	17,182	5,560
EBIT Margin	15.05%	14.72%	18.91%	6.83%
Effective Tax Rate	49.44%	53.95%	22.16%	40.92%
Advertising Expenses	-	1,446	994.74	482.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.